These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25804408)

  • 1. Quantifying vitamin K-dependent holoprotein compaction caused by differential γ-carboxylation using high-pressure size exclusion chromatography.
    Vanderslice NC; Messer AS; Vadivel K; Bajaj SP; Phillips M; Fatemi M; Xu W; Velander WH
    Anal Biochem; 2015 Jun; 479():6-14. PubMed ID: 25804408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the factor IX gamma-carboxyglutamic acid domain to the vitamin K-dependent gamma-glutamyl carboxylase active site induces an allosteric effect that may ensure processive carboxylation and regulate the release of carboxylated product.
    Lin PJ; Straight DL; Stafford DW
    J Biol Chem; 2004 Feb; 279(8):6560-6. PubMed ID: 14660587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.
    Gillis S; Furie BC; Furie B; Patel H; Huberty MC; Switzer M; Foster WB; Scoble HA; Bond MD
    Protein Sci; 1997 Jan; 6(1):185-96. PubMed ID: 9007991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tethered processivity of the vitamin K-dependent carboxylase: factor IX is efficiently modified in a mechanism which distinguishes Gla's from Glu's and which accounts for comprehensive carboxylation in vivo.
    Stenina O; Pudota BN; McNally BA; Hommema EL; Berkner KL
    Biochemistry; 2001 Aug; 40(34):10301-9. PubMed ID: 11513608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the propeptide and gamma-glutamic acid domain of factor IX for in vitro carboxylation by the vitamin K-dependent carboxylase.
    Stanley TB; Wu SM; Houben RJ; Mutucumarana VP; Stafford DW
    Biochemistry; 1998 Sep; 37(38):13262-8. PubMed ID: 9748333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX.
    Freedman SJ; Blostein MD; Baleja JD; Jacobs M; Furie BC; Furie B
    J Biol Chem; 1996 Jul; 271(27):16227-36. PubMed ID: 8663165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxylase overexpression effects full carboxylation but poor release and secretion of factor IX: implications for the release of vitamin K-dependent proteins.
    Hallgren KW; Hommema EL; McNally BA; Berkner KL
    Biochemistry; 2002 Dec; 41(50):15045-55. PubMed ID: 12475254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa.
    Wojcik EG; Van Den Berg M; Poort SR; Bertina RM
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):629-36. PubMed ID: 9169594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid.
    Morita T; Isaacs BS; Esmon CT; Johnson AE
    J Biol Chem; 1984 May; 259(9):5698-704. PubMed ID: 6425296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
    Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
    J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of recombinant chimeric human protein C and activated protein C containing the gamma-carboxyglutamic acid and trailing helical stack domains of protein C replaced by those of human coagulation factor IX.
    Christiansen WT; Castellino FJ
    Biochemistry; 1994 May; 33(19):5901-11. PubMed ID: 8180219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for Ca2+ binding to the gamma-carboxyglutamic acid and epidermal growth factor-like regions of factor IX. Studies using intact domains isolated from controlled proteolytic digests of bovine factor IX.
    Astermark J; Björk I; Ohlin AK; Stenflo J
    J Biol Chem; 1991 Feb; 266(4):2430-7. PubMed ID: 1989994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
    Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
    J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The entire gamma-carboxyglutamic acid- and helical stack-domains of human coagulation factor IX are required for optimal binding to its endothelial cell receptor.
    Prorok M; Geng JP; Warder SE; Castellino FJ
    Int J Pept Protein Res; 1996 Sep; 48(3):281-5. PubMed ID: 8897096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The propeptides of human protein C, factor VII, and factor IX are exchangeable with regard to directing gamma-carboxylation of these proteins.
    Geng JP; Castellino FJ
    Thromb Haemost; 1996 Aug; 76(2):205-7. PubMed ID: 8865532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved activity and expression of recombinant human factor IX by propeptide engineering.
    Vatandoost J; Bos MHA
    Daru; 2019 Dec; 27(2):653-660. PubMed ID: 31637661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of the recombinant factor VIIa in rat bone: importance of the Gla-domain and relevance to factor IX, another vitamin K-dependent clotting factor.
    Thomsen MK; Wildgoose P; Nilsson P; Hedner U
    Pharmacol Toxicol; 1993 Sep; 73(3):127-32. PubMed ID: 7903449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GGCX mutants that impair hemostasis reveal the importance of processivity and full carboxylation to VKD protein function.
    Rishavy MA; Hallgren KW; Wilson LA; Hiznay JM; Runge KW; Berkner KL
    Blood; 2022 Oct; 140(15):1710-1722. PubMed ID: 35767717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor IX oligomerization underlies reduced activity upon disruption of physiological conditions.
    Simhadri VL; Hamasaki-Katagiri N; Tseng SC; Bentley AA; Zichel R; Hershko AY; Komar AA; Kimchi-Sarfaty C
    Haemophilia; 2014 Mar; 20(2):e157-63. PubMed ID: 24417758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step.
    Hallgren KW; Qian W; Yakubenko AV; Runge KW; Berkner KL
    Biochemistry; 2006 May; 45(17):5587-98. PubMed ID: 16634640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.